Cubist Systematic Strategies, LLC Ovid Therapeutics Inc. Transaction History

Cubist Systematic Strategies, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.88 - $2.85 $9,691 - $14,691	5,155 New	5,155 $13,000
Q1 2022 May 16, 2022	SELL	$2.65 - $3.49 $28,100 - $37,007	-10,604 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.13 - $3.73 $21,643 - $25,792	-6,915 Reduced 39.47%	10,604 $34,000
Q3 2021 Nov 15, 2021	BUY	$3.31 - $4.04 $57,987 - $70,776	17,519 New	17,519 $59,000
Q2 2021 Aug 16, 2021	SELL	$3.3 - $4.49 $161,340 - $219,520	-48,891 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.42 - $4.47 $118,316 - $218,542	48,891 New	48,891 $197,000
Q4 2020 Feb 16, 2021	SELL	$2.28 - $6.84 $44,024 - $132,073	-19,309 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$5.39 - $8.24 $5,972 - $9,129	-1,108 Reduced 5.43%	19,309 $111,000
Q2 2020 Aug 14, 2020	BUY	$2.67 - $7.91 $54,513 - $161,498	20,417 New	20,417 $150,000
Q1 2020 May 15, 2020	SELL	$2.03 - $4.35 $52,761 - $113,060	-25,991 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.08 - $5.06 $54,061 - $131,514	25,991 New	25,991 $108,000
Q2 2019 Aug 14, 2019	SELL	$1.59 - $2.14 $16,445 - $22,134	-10,343 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.77 - $3.56 $18,307 - $36,821	10,343 New	10,343 $18,000

39.2M

10.3K

200

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $79.6M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.